Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11152)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Han KQ, He XQ, Ma MY, Guo XD, Zhang XM, Chen J, Han H, Zhang WW, Zhu QG, Nian H, Ma LJ. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma. World J Gastroenterol 2015; 21(16): 4864-4874 [PMID: 25944999 DOI: 10.3748/wjg.v21.i16.4864] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i16/4864.htm |
| Number | Citing Articles |
| 1 |
KE-QI HAN, XUE-QUN HE, MENG-YU MA, XIAO-DONG GUO, XUE-MIN ZHANG, JIE CHEN, HUI HAN, WEI-WEI ZHANG, QUAN-GANG ZHU, WEN-ZHAO ZHAO. Targeted silencing of CXCL1 by siRNA inhibits tumor growth and apoptosis in hepatocellular carcinoma. International Journal of Oncology 2015; 47(6): 2131 doi: 10.3892/ijo.2015.3203
|
| 2 |
Gang Wang, Xin Zhao, De-Chun Li. Expression of HIP/PAP in hepatocellular carcinoma and effect of siRNA on migration and invasion in HCC cells. Asian Pacific Journal of Tropical Medicine 2015; 8(10): 848 doi: 10.1016/j.apjtm.2015.09.012
|
| 3 |
Tianqi Wang, Guangyong Sun, Yaning Wang, Shuxiang Li, Xinyan Zhao, Chunpan Zhang, Hua Jin, Dan Tian, Kai Liu, Wen Shi, Yue Tian, Dong Zhang. The immunoregulatory effects of CD8 T‐cell–derived perforin on diet‐induced nonalcoholic steatohepatitis. The FASEB Journal 2019; 33(7): 8490 doi: 10.1096/fj.201802534RR
|
| 4 |
Yin Xia, Linlin Zhou, Hung-Chih Yang, Chen-Wei Yu. Chemokine CCL5 immune subtypes of human liver cancer with prognostic significance. International Immunopharmacology 2022; 113: 109372 doi: 10.1016/j.intimp.2022.109372
|
| 5 |
Judit López‐Luque, Daniel Caballero‐Díaz, Adoración Martinez‐Palacián, César Roncero, Joaquim Moreno‐Càceres, María García‐Bravo, Esther Grueso, Almudena Fernández, Eva Crosas‐Molist, María García‐Álvaro, Annalisa Addante, Esther Bertran, Angela M. Valverde, Águeda González‐Rodríguez, Blanca Herrera, Lluis Montoliu, Teresa Serrano, Jose‐Carlos Segovia, Margarita Fernández, Emilio Ramos, Aránzazu Sánchez, Isabel Fabregat. Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis. Hepatology 2016; 63(2): 604 doi: 10.1002/hep.28134
|
| 6 |
Khushboo Gulati, Krishnakant Gangele, Nipanshu Agarwal, Minal Jamsandekar, Dinesh Kumar, Krishna Mohan Poluri. Molecular cloning and biophysical characterization of CXCL3 chemokine. International Journal of Biological Macromolecules 2018; 107: 575 doi: 10.1016/j.ijbiomac.2017.09.032
|
| 7 |
Shan Shao, Wanxing Duan, Qinhong Xu, Xuqi Li, Liang Han, Wei Li, Dong Zhang, Zheng Wang, Jianjun Lei. Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8148510
|
| 8 |
Anna Piotrowska, Ewelina Rojewska, Katarzyna Pawlik, Grzegorz Kreiner, Agata Ciechanowska, Wioletta Makuch, Irena Nalepa, Joanna Mika. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02198
|
| 9 |
Wei Li, Shuanlin Miao, Manyuan Miao, Renshuan Li, Xiaopeng Cao, Kun Zhang, Genzuan Huang, Bin Fu. Hedgehog Signaling Activation in Hepatic Stellate Cells Promotes Angiogenesis and Vascular Mimicry in Hepatocellular Carcinoma. Cancer Investigation 2016; 34(9): 424 doi: 10.1080/07357907.2016.1227442
|
| 10 |
Hikmet Akkiz, Brian I. Carr, Harika G. Bag, Ümit Karaoğullarından, Kendal Yalçın, Nazim Ekin, Ayşegül Özakyol, Engin Altıntaş, Hatice Y. Balaban, Halis Şimşek, Ahmet Uyanıkoğlu, Ayhan Balkan, Sedef Kuran, Oğuz Üsküdar, Yakup Ülger, Burak Güney, Anil Delik. Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma. International Journal of Clinical Practice 2021; 75(2) doi: 10.1111/ijcp.13593
|
| 11 |
Yu Yan, Cancan Zhou, Jie Li, Ke Chen, Guanghui Wang, Guangbing Wei, Mingwei Chen, Xuqi Li. Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1. Molecular and Cellular Biochemistry 2017; 434(1-2): 17 doi: 10.1007/s11010-017-3031-z
|
| 12 |
Jinlin Zhong, Rongling Pan, Miao Gao, Yuqian Mo, Xin Peng, Guoxiao Liang, Zixuan Chen, Jinlin Du, Zhigang Huang. Identification and validation of a T cell marker gene-based signature to predict prognosis and immunotherapy response in gastric cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48930-8
|
| 13 |
Chunxun Liu, Zhaowei Qu, Haoran Zhao, Peng Wang, Chao Zhan, Yubao Zhang. Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma. BMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-023-05323-y
|
| 14 |
Mengna Wu, Huajie Miao, Rong Fu, Jie Zhang, Wenjie Zheng . Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma. Current Molecular Pharmacology 2020; 13(4): 261 doi: 10.2174/1874467213666200224102820
|
| 15 |
Yuxi Gu, Shouyi Tang, Zhen Wang, Luyao Cai, Haosen Lian, Yingqiang Shen, Yu Zhou. A pan-cancer analysis of the prognostic and immunological role of β-actin (ACTB) in human cancers. Bioengineered 2021; 12(1): 6166 doi: 10.1080/21655979.2021.1973220
|
| 16 |
Zhengyi Wu, Liang Sun, Yongkang Xu, He Huang, Zhipeng Wu, Bingbing Qiu, Jinlong Yan, Xiangbao Yin. The Value of Chemokine and Chemokine Receptors in Diagnosis, Prognosis, and Immunotherapy of Hepatocellular Carcinoma. Cancer Management and Research 2024; : 403 doi: 10.2147/CMAR.S450959
|
| 17 |
Yanyan Wen, Ningning Song, Yueyou Peng, Weiwei Wu, Qixiong Lin, Minjie Cui, Rongrong Li, Qiufeng Yu, Sixue Wu, Yongkang Liang, Wei Tian, Yanfeng Meng. Radiofrequency enhances drug release from responsive nanoflowers for hepatocellular carcinoma therapy. Beilstein Journal of Nanotechnology 2024; 15: 569 doi: 10.3762/bjnano.15.49
|
| 18 |
Óscar Brochado-Kith, Isidoro Martínez, Juan Berenguer, Juan González-García, Sergio Salgüero, Daniel Sepúlveda-Crespo, Cristina Díez, Víctor Hontañón, Luis Ibañez-Samaniego, Leire Pérez-Latorre, Amanda Fernández-Rodríguez, María Ángeles Jiménez-Sousa, Salvador Resino. HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.723196
|